Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Clin Cancer Res. 2017 May 18;23(17):5162–5175. doi: 10.1158/1078-0432.CCR-16-1686

Table 2.

Multivariate analysis of SMAD4 expression adjusted for other patient characteristics in patients with recurrent HNSCC.

Overall Survival
Characteristic HR 95% CI P value
SMAD4
 Negative vs. positive 3.05 [1.34, 6.95] 0.008
M stage
 M1 vs. M0 5.85 [1.83, 18.67] 0.003
Primary tumor site
 Oropharynx vs. other 4.07 [1.65, 10.06] 0.002
Age 1.008 [0.98, 1.04] 0.64